Pluristem Therapeutics Inc (PSTI)

[n3m3sis]

To be or not to be, that is the question....

PSTI, PLX and PMCB were the first stocks I ever bought.
Each one has their own unique approach.

I went for PLX for what they are doing for Cystic Fibrosis and April's full phase 2 results could well bring them a partnership offer, since the two Big P drugs they are up against are well below the PLX offering in efficacy and safety. This may well take PLX above $5/8 first if a partnership can be agreed.

PSTI has so much going for it with the placenta cells. They are determined to become BIG P in their own right, turning down numerous offers of partnership and licensing. The type of clients that PSTI are looking to cultivate means that one governmental contract will take them up into the stratosphere, especially if it is a major government. Others will jump on the bandwagon after that, especially in the case of ARS.
Thus, I have to agree with Midas assessment.... it will be very interesting to see how this pans out.

GO $PSTI